This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Study of Lasmiditan (LY573144) Over Four Migrain...
Clinical trial

A Study of Lasmiditan (LY573144) Over Four Migraine Attacks

Read time: 2 mins
Last updated:24th Jun 2019
Identifier: NCT03670810

The reason for this study is to see how effective and safe the study drug known as lasmiditan is in the acute treatment of 4 migraine attacks with or without aura.

Study Type: Interventional  (Clinical Trial)
Estimated Enrollment: 1600 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks
Actual Study Start Date: June 24, 2019
Estimated Primary Completion Date: March 26, 2020
Estimated Study Completion Date: March 29, 2021

- Experimental:
Lasmiditan High Dose
- Experimental: Lasmiditan Low Dose
- Placebo Comparator: Control

Category Value
Date last updated at source 2019-11-19
Study type(s) Interventional
Expected enrolment 1600
Study start date 2019-06-24
Estimated primary completion date 2020-03-26

View full details